News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Nelson Dusetti: One of the first publications from the Franco-Argentine Network for Pancreatic Cancer
Photo taken from cancercenter.com
Jul 24, 2024, 22:22

Nelson Dusetti: One of the first publications from the Franco-Argentine Network for Pancreatic Cancer

“We are thrilled to announce one of the first publications from the Franco-Argentine Network for Pancreatic Cancer advancing global research on this malignancy.

This study identifies the ABCC4/MRP4 transporter as a crucial factor in pancreatic cancer aggressiveness and metastasis. ABCC4 promotes epithelial-mesenchymal transition (EMT), enhancing cell motility and chemoresistance. High ABCC4 levels correlate with EMT markers, making it a valuable prognostic marker and a potential therapeutic target, particularly for aggressive basal-like/squamous PDAC subtypes.“
A

The xenobiotic transporter ABCC4/MRP4 promotes epithelial mesenchymal transition in pancreatic cancer published in Frontiers

Autors: S. N. Gancedo, A. Sahores, N. Gómez, N. Di Siervi, M. May, A. Yaneff, M. G. de Sousa Serro, N. Fraunhoffer, N. Dusetti, J. Iovanna, C. Shayo, C. A. Davio, B. González

Nelson Dusetti

Source: /LinkedIn

Scientific Director of the company Predicting Med (CSO) and Chair of TRANSLATE-IT CRCM. He is also research director at INSERM. He is the Head of the Department of Translational Research and Innovative Therapies at CRCM.”

A. Sahores A. Yaneff B. González C. A. Davio C. Shayo cancer Cancer research epithelial-mesenchymal transition (EMT) Franco-Argentine Network for Pancreatic Cancer Frontiers J. Iovanna M. G. de Sousa Serro M. May N. Di Siervi N. Fraunhoffer N. Gómez Nelson Dusetti. OncoDaily Oncology Pancreatic Cancer S. N. Gancedo
Special Coverage
Insight
Dec 23, 2024, 21:21
Anil D’Cruz: A great initial step in improving access to healthcare for all
Insight
Dec 23, 2024, 21:19
Ahmed Kotb: CML Treatment Algorithm guided by NCCN and ELN
Insight
Dec 23, 2024, 21:16
Hung Trinh: CAR-T cell therapy for the treatment of adult high-grade gliomas
Insight
Dec 23, 2024, 21:14
Mainak Bardhan: Zero-shot patient-to-trial matching with large language models
Insight
Dec 23, 2024, 21:09
Supriya Peshin: Unpacking Trastuzumab-Induced Cardiomyopathy
Insight
Dec 23, 2024, 20:37
Guilherme Nader Marta: Two perspectives on anthracycline use in breast cancer
Blog
Dec 23, 2024, 20:33
Enrique Grande: When this time of year comes around we all look back and evaluate ourselves
Science
Dec 23, 2024, 20:29
Alba Fiorentino: An oligometastatic lung cancer case report with a durable complete metabolic response
Blog
Dec 23, 2024, 20:18
Vun-Sin Lim: Recap of the ISMTE Asia-Pacific Advisory Council office hour events
Blog
Dec 23, 2024, 20:14
Webinar on how to get the most out of your MASCC membership
Blog
Dec 23, 2024, 20:13
Pamela was diagnosed with stage III colon cancer at the age of 49 - Colorectal Cancer Alliance
Career
Dec 23, 2024, 20:11
MinhTri Nguyen: Thrilled to be selected for the Stanford Physician Leadership Certificate Program